AATF and Miyoshi myopathy: Since Che-1 silencing is able to induce apoptosis or cell cycle arrest and sensitize MM cells to treatment with proteasome and BET inhibitors [2, 15], targeting Che-1 by using CK2 inhibitors could represent an interesting novel therapeutic approach.